Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

and the overexpression of various HDACs in many cancer types, HDAC inhibitors have been extensively investigated as anticancer agents in recent years. “HDAC inhibitors induce cell death in ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The HDAC inhibitor was given an accelerated approval ... It's the third time in recent months that BMS has trimmed down the uses for its cancer drugs, coming after it withdrew approvals for ...

CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in the San Francisco Bay Area, was established as an independent entity in 2024 after licensing ivaltinostat ...